Avid Bioservices, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Tustin, CA
SEC filing record 1 source field available
Fiscal year end
30 April
Avid Bioservices, Inc. has filed 1,388 SEC EDGAR filings since 14 Sep 1995

SEC filing history

Showing 876-900 of 992 matching filings.

Per page
25
Current page
36
4

OWNERSHIP DOCUMENT

Filing date
15 Mar 2012
Reporting date
14 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-180028

FORM S-3

Filing date
09 Mar 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32839

CURRENT REPORT ON FORM 8-K

Filing date
09 Mar 2012
Reporting date
09 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32839

FORM 8-K

Filing date
09 Mar 2012
Reporting date
09 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
21 Feb 2012
Reporting date
17 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
21 Feb 2012
Reporting date
17 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
21 Feb 2012
Reporting date
17 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
21 Feb 2012
Reporting date
17 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
21 Feb 2012
Reporting date
17 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
21 Feb 2012
Reporting date
17 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
21 Feb 2012
Reporting date
17 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
21 Feb 2012
Reporting date
17 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32839

PEREGRINE PHARMACEUTICALS, INC.

Filing date
21 Feb 2012
Reporting date
17 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-37393

SC 13G/A filing

Filing date
14 Feb 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-37393

SC 13G/A filing

Filing date
13 Feb 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32839

CURRENT REPORT ON FORM 8-K

Filing date
29 Dec 2011
Reporting date
29 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-178452

PEREGRINE PHARMACEUTICALS, INC. FORM S-8 REGISTRATION STATEMENT

Filing date
12 Dec 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32839

CURRENT REPORT ON FORM 8-K

Filing date
12 Dec 2011
Reporting date
12 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32839

CURRENT REPORT ON FORM 8-K

Filing date
06 Dec 2011
Reporting date
06 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-32839

CURRENT REPORT ON FORM 8-K

Filing date
22 Nov 2011
Reporting date
22 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Nov 2011
Reporting date
31 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Nov 2011
Reporting date
31 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Nov 2011
Reporting date
31 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .